These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 14085591)

  • 21. DIFFERENCES IN THE INTERACTION OF TRIIODOTHYRONINE-131-I WITH SERUM PROTEINS IN VITRO.
    MITCHELL ML; BRADFORD AH; COLLINS S
    J Clin Endocrinol Metab; 1964 Sep; 24():867-74. PubMed ID: 14216476
    [No Abstract]   [Full Text] [Related]  

  • 22. [USE OF METHIMAZOLE AS A PRE-TREAMENT DRUG IN I-131 THERAPY OF SEVERE THYROTOXICOSIS WITH EXTREMELY HIGH IODINE METABOLISM RATE].
    OELSSNER W; LOEBE J
    Radiobiol Radiother (Berl); 1964; 5():619-23. PubMed ID: 14317781
    [No Abstract]   [Full Text] [Related]  

  • 23. [USE OF THE ANALYSIS OF DISCRIMINATING FUNCTIONS IN THE DIAGNOSIS OF THYROID FUNCTION. 3. DISCRIMINATING CAPACITY OF 3 THYROID FUNCTION TESTS IN SUBJECTS WITH NORMOFUNCTIONING GOITER (208 CASES) AND WITH HYPERTHYROIDISM (178 CASES)].
    MINOZZI M; FAGGIANO M; COLIGIANNI A; ORIO F
    Folia Endocrinol; 1964 Jun; 17():348-55. PubMed ID: 14210722
    [No Abstract]   [Full Text] [Related]  

  • 24. TRIIODOTHYRONINE BINDING TO RED BLOOD CELLS AND ACHILLES TENDON REFLEX AS THYROID INDICES.
    SABEH G; SARVER ME; MOSES C; DANOWSKI TS
    Am J Med Sci; 1964 Sep; 248():253-9. PubMed ID: 14210300
    [No Abstract]   [Full Text] [Related]  

  • 25. [CHANGES IN THE I-131 CONTENT OF THE THYROID GLAND WHEN USED FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES IN PATIENTS WITH THYROTOXICOSIS].
    LIVERGANT IuE; CHEBOTAREVA ED
    Med Radiol (Mosk); 1964 Aug; 9():16-8. PubMed ID: 14250915
    [No Abstract]   [Full Text] [Related]  

  • 26. THYROTOXICOSIS OCCURRING IN TWO PATIENTS ON PROLONGED HIGH DOSES OF STEROIDS.
    BROWN DM; LOWMAN JT
    N Engl J Med; 1964 Feb; 270():278-81. PubMed ID: 14074653
    [No Abstract]   [Full Text] [Related]  

  • 27. [LATE RESULTS OF RADIOIODINE THERAPY IN BASEDOW'S DISEASE].
    FAZAKAS S; PETRANYI G
    Orv Hetil; 1964 May; 105():932-4. PubMed ID: 14159635
    [No Abstract]   [Full Text] [Related]  

  • 28. SOME PRESENT DAY CONCEPTS OF THE THERAPY OF DISEASES OF THE THYROID GLAND.
    HAMOLSKY MW
    R I Med J; 1964 Jul; 47():336-9. PubMed ID: 14179935
    [No Abstract]   [Full Text] [Related]  

  • 29. [CRITICAL EVALUATION OF BASAL METABOLISM TESTS USED BY THE NATIONAL HEALTH SERVICE].
    ASZODI Z
    Orv Hetil; 1964 Dec; 105():2325-9. PubMed ID: 14228964
    [No Abstract]   [Full Text] [Related]  

  • 30. [CLINICAL SIGNIFICANCE OF THYROID FUNCTION TESTS AFTER I-131 THERAPY FOR HYPERTHYROIDISM].
    SHIOTA K; KURATA N; TORIBE H; OKUSU T; KURIOKA Y; FUJITA E; MURAHASHI Y
    Nihon Naibunpi Gakkai Zasshi; 1964 May; 40():126-37. PubMed ID: 14147858
    [No Abstract]   [Full Text] [Related]  

  • 31. [THE TOXIC THYROID ADENOMA. CURRENT DIAGNOSTIC METHODS USING RADIOACTIVE IODINE].
    DECOURT J; JUNGERS
    Folia Clin Int (Barc); 1963 Oct; 13():451-8. PubMed ID: 14098966
    [No Abstract]   [Full Text] [Related]  

  • 32. [ON METHODS FOR THE DETERMINATION OF THE QUANTITY AND FREQUENCY OF I-131 ADMINISTRATION IN THE TREATMENT OF THYROTOXICOSIS].
    GARAGASHIAN AA
    Med Radiol (Mosk); 1964 Aug; 9():18-22. PubMed ID: 14250916
    [No Abstract]   [Full Text] [Related]  

  • 33. [ENZYME CONTENT IN THE BLOOD OF PATIENTS WITH THYROTOXICOSIS BEFORE AND AFTER ADMINISTRATION OF THERAPEUTIC DOSES OF I-131].
    SPESIVTSEVA VG; BELOUSOVA ND
    Med Radiol (Mosk); 1963 Sep; 8():40-4. PubMed ID: 14100266
    [No Abstract]   [Full Text] [Related]  

  • 34. [KINETICS OF SOME ION EXCHANGES IN DIFFERENT THYROID CONDITIONS. STUDY USING THE I-131 AND BR-82 ISOTOPE MIXTURE].
    FERNANDEZ Y; DUTREIX J
    Pathol Biol; 1963 Oct; 11():1061-9. PubMed ID: 14093234
    [No Abstract]   [Full Text] [Related]  

  • 35. [THE RATIO OF PROTEIN-BOUND IODINE AND TOTAL IODINE IN THE BLOOD OF PATIENTS WITH THYROID DISEASE STUDIED WITH RADIOIODINE-I-131].
    GENNARELLI L; LENTI R
    Minerva Med; 1964 Aug; 55():2444-7. PubMed ID: 14202873
    [No Abstract]   [Full Text] [Related]  

  • 36. [STATUS OF HYPERTHYROID CASES CONSIDERED AS CURED DESPITE ABNORMAL FIXATION OF RADIOACTIVE IODINE IN THE THYROID AT THE END OF ISOTOPE TREATMENT].
    LINQUETTE M; SWYNGEDAUW J; MAY JP; FOSSATI P
    Ann Endocrinol (Paris); 1963; 24():630-6. PubMed ID: 14051318
    [No Abstract]   [Full Text] [Related]  

  • 37. PERTECHNETATE-99M LOCALIZATION IN MAN WITH APPLICATIONS TO THYROID SCANNING AND THE STUDY OF THYROID PHYSIOLOGY.
    ANDROS G; HARPER PV; LATHROP KA
    J Clin Endocrinol Metab; 1965 Aug; 25():1067-76. PubMed ID: 14328377
    [No Abstract]   [Full Text] [Related]  

  • 38. [ON FUNCTIONAL CONDITIONS OF THE THYROID GLAND IN PATIENTS WITH MULTIPLE SCLEROSIS, VARIOUS DEMYELINATING DISEASES AND THYROTOXICOSIS].
    VALTNERE AL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1964; 64():365-7. PubMed ID: 14140470
    [No Abstract]   [Full Text] [Related]  

  • 39. HYPERTHYROIDISM IN PATIENTS OVER 65.
    BARTELS EC
    Geriatrics; 1965 Jun; 20():459-62. PubMed ID: 14306155
    [No Abstract]   [Full Text] [Related]  

  • 40. LABELED IODOALBUMIN IN THE PLASMA IN THYROTOXICOSIS AFTER I-125 AND I-131.
    STANBURY JB; JANSSEN MA
    J Clin Endocrinol Metab; 1963 Oct; 23():1056-8. PubMed ID: 14067892
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.